The emerging tick-borne Crimean-Congo haemorrhagic fever virus: A narrative review.


Journal

Travel medicine and infectious disease
ISSN: 1873-0442
Titre abrégé: Travel Med Infect Dis
Pays: Netherlands
ID NLM: 101230758

Informations de publication

Date de publication:
Historique:
received: 04 12 2019
revised: 25 08 2020
accepted: 26 08 2020
pubmed: 7 9 2020
medline: 21 8 2021
entrez: 6 9 2020
Statut: ppublish

Résumé

Crimean-Congo Haemorrhagic Fever (CCHF) is an increasingly relevant viral zoonosis caused by the negative-sense single-stranded (ss) RNA Crimean-Congo Haemorrhagic Fever Orthonairovirus (CCHFV) (Nairoviridae family, Bunyavirales order). The viral genome is divided into three segments (L-M-S) of distinct size and functions. The infection is generally mediated by a tick vector, in particular belonging to the Hyalomma genus, and the transmission follows a tick-vertebrate-tick ecologic cycle, with asymptomatic infected animals functioning as reservoirs and amplifiers for CCHFV. Human hosts could be infected primarily through infected ticks or by contact with infected hosts or their body fluids and tissues, also in a nosocomial way and in occupational contexts. Infected symptomatic patients generally manifest a nonspecific illness, which progresses across four stages, with possibly lethal outcomes. Disease outbreaks show a widespread geographic diffusion and a highly variable mortality rate, dramatically peaking in untreated patients. The lack of an adequate animal model and the elevated virus biological risk (only manageable under biosafety level 4 conditions) represent strongly limiting factors for a better characterization of the disease and for the development of specific therapies and vaccines. The present review discusses updated information on CCHFV-related disease, including details about the virus (taxonomy, structure, life cycle, transmission modalities) and considering CCHF pathogenesis, epidemiology and current strategies (diagnostic, therapeutic and preventive).

Identifiants

pubmed: 32891725
pii: S1477-8939(20)30367-7
doi: 10.1016/j.tmaid.2020.101871
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101871

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Enrica Serretiello (E)

Section of Microbiology and Virology, University Hospital Luigi Vanvitelli of Naples, Naples, Italy.

Roberta Astorri (R)

Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania "Luigi Vanvitelli", Naples, Italy; Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Annalisa Chianese (A)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Debora Stelitano (D)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Carla Zannella (C)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Veronica Folliero (V)

Section of Microbiology and Virology, University Hospital Luigi Vanvitelli of Naples, Naples, Italy.

Biagio Santella (B)

Section of Microbiology and Virology, University Hospital Luigi Vanvitelli of Naples, Naples, Italy.

Marilena Galdiero (M)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Gianluigi Franci (G)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy; Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi (SA), Italy. Electronic address: gfranci@unisa.it.

Massimiliano Galdiero (M)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy. Electronic address: massimiliano.galdiero@unicampania.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH